CA2666308C - Polypeptides ayant des proprietes antiinflammatoires accrues et cytotoxiques reduites et procedes associes - Google Patents

Polypeptides ayant des proprietes antiinflammatoires accrues et cytotoxiques reduites et procedes associes Download PDF

Info

Publication number
CA2666308C
CA2666308C CA2666308A CA2666308A CA2666308C CA 2666308 C CA2666308 C CA 2666308C CA 2666308 A CA2666308 A CA 2666308A CA 2666308 A CA2666308 A CA 2666308A CA 2666308 C CA2666308 C CA 2666308C
Authority
CA
Canada
Prior art keywords
igg
ivig
region
alpha
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2666308A
Other languages
English (en)
Other versions
CA2666308A1 (fr
Inventor
Falk Nimmerjahn
Yoshikatsu Kaneko
Jeffrey V. Ravetch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/041791 external-priority patent/WO2007055916A2/fr
Priority claimed from PCT/US2007/008396 external-priority patent/WO2007117505A2/fr
Application filed by Rockefeller University filed Critical Rockefeller University
Priority claimed from PCT/US2007/072771 external-priority patent/WO2008057634A2/fr
Publication of CA2666308A1 publication Critical patent/CA2666308A1/fr
Application granted granted Critical
Publication of CA2666308C publication Critical patent/CA2666308C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un polypeptide contenant au moins une région IgG Fc, ladite région IgG Fc étant glycosylée avec au moins une fonction galactose reliée à une fonction acide sialique terminale respective par une liaison .alpha. 2, 6, et ledit polypeptide ayant une activité antiinflammatoire accrue en comparaison d'un anticorps non purifié.
CA2666308A 2006-10-26 2007-07-03 Polypeptides ayant des proprietes antiinflammatoires accrues et cytotoxiques reduites et procedes associes Active CA2666308C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
USPCT/US06/41791 2006-10-26
PCT/US2006/041791 WO2007055916A2 (fr) 2005-11-07 2006-10-27 Reactifs, procedes et systemes pour la selection d'un anticorps cytotoxique ou d'une variante
USPCT/US07/08396 2007-04-03
PCT/US2007/008396 WO2007117505A2 (fr) 2006-04-05 2007-04-03 Polypeptides presentant des proprietes anti-inflammatoires accrues et des proprietes cytotoxiques reduites, et procedes coorespondants
PCT/US2007/072771 WO2008057634A2 (fr) 2006-10-26 2007-07-03 Polypeptides ayant des propriétés antiinflammatoires accrues et cytotoxiques réduites et procédés associés

Publications (2)

Publication Number Publication Date
CA2666308A1 CA2666308A1 (fr) 2008-05-15
CA2666308C true CA2666308C (fr) 2014-09-23

Family

ID=40792829

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2666308A Active CA2666308C (fr) 2006-10-26 2007-07-03 Polypeptides ayant des proprietes antiinflammatoires accrues et cytotoxiques reduites et procedes associes

Country Status (3)

Country Link
JP (1) JP2010512306A (fr)
CA (1) CA2666308C (fr)
IL (1) IL197920A0 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR085302A1 (es) * 2011-02-24 2013-09-18 Sanofi Sa Metodo de produccion de anticuerpos sialilados
UY34317A (es) 2011-09-12 2013-02-28 Genzyme Corp Anticuerpo antireceptor de célula T (alfa)/ß
KR102420934B1 (ko) * 2013-03-11 2022-07-15 젠자임 코포레이션 과글리코실화된 결합 폴리펩티드
PT3129067T (pt) 2014-03-19 2023-03-22 Genzyme Corp Glicomanipulação em sítios específicos de frações de direcionamento
KR102549282B1 (ko) * 2019-11-18 2023-06-30 건국대학교 산학협력단 시알산화된 면역글로불린을 유효성분으로 포함하는 염증성 질환의 치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2218806T3 (es) * 1997-01-16 2004-11-16 Neose Technologies, Inc. Sialilacion practica in vitro de glicoproteinas recombinantes.
DK2163640T3 (da) * 1999-04-15 2012-03-05 Crucell Holland Bv Rekombinant proteinproduktion i en human celle indeholdende mindst ét E1-protein af adenovirus
CA2424977C (fr) * 2000-10-06 2008-03-18 Kyowa Hakko Kogyo Co., Ltd. Procede de purification d'un anticorps

Also Published As

Publication number Publication date
JP2010512306A (ja) 2010-04-22
CA2666308A1 (fr) 2008-05-15
IL197920A0 (en) 2011-08-01

Similar Documents

Publication Publication Date Title
US20230121427A1 (en) Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
US20220162290A1 (en) Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
US20080206246A1 (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
WO2008057634A2 (fr) Polypeptides ayant des propriétés antiinflammatoires accrues et cytotoxiques réduites et procédés associés
US20120134988A1 (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
CA2666308C (fr) Polypeptides ayant des proprietes antiinflammatoires accrues et cytotoxiques reduites et procedes associes
NZ597651A (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
US20110150867A1 (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
US20240279314A1 (en) Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods

Legal Events

Date Code Title Description
EEER Examination request